RecruitingNCT04154332

Exosome Cargo From Preeclampsia Patients

Exosome Cargo From Preeclamptic Patients Mediates Endothelial Dysfunction, Subsequent Cardiovascular Remodeling, and the Preeclamptic Phenotype


Sponsor

University of Alabama at Birmingham

Enrollment

64 participants

Start Date

Dec 2, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

Although extensively studied, the cause of preeclampsia remains uncertain other than it is thought that the placenta plays a critical role in the development of preeclampsia. Recent data revealed that exosomes released from the placenta could cause preeclampsia by transporting specific cargo responsible for the pathophysiological changes associated with the systemic disease. By isolating these exosomes from maternal blood and placental tissue in patients diagnosed with preeclampsia and studying their biochemical, cellular and molecular mechanism in an animal model, the investigators hope to elucidate the critical role that exosomal cargo plays in the development of preeclampsia and cardiovascular remodeling. This will be accomplished by obtaining patient samples from volunteers delivering at the Women and Infants Center and taking the samples to the lab for quantification, characterization, and identification of key functional roles through in/ex vivo, in vitro, and profiling studies. The investigators believe this work will be valuable as hope exists to define the functional role exosomes play in the development of preeclampsia that leads to cardiovascular remodeling. Data from this study will shed more light on the functional role of exosomal cargo in normal and pathological pregnancies and point towards novel therapeutic intervention strategies for preeclampsia associated with cardiovascular disease.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting blood samples from pregnant women who have preeclampsia (a dangerous high blood pressure condition during pregnancy) to study tiny particles called exosomes that are released into the bloodstream. Researchers want to understand what signals these particles carry and how they might contribute to the disease, with the goal of finding better ways to detect or treat preeclampsia. **You may be eligible if...** - You are 18 or older and pregnant - You have been diagnosed with preeclampsia with severe features (very high blood pressure after 20 weeks and protein in the urine or other organ complications), OR - You are a healthy pregnant control with no blood pressure issues **You may NOT be eligible if...** - You do not have a clear preeclampsia diagnosis (if in the patient group) - You are a healthy control with any blood pressure disorder during pregnancy Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSample collection

Blood, urine, placental samples, and the patient's vascular reactivity will be collected from each person enrolled in this study.


Locations(1)

University of Alabama at Birmingham

Birmingham, Alabama, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04154332


Related Trials